Gate Bioscience | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

7,344 results for “Gate Bioscience”

Trials

View all 4828 →

Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers

18 participants · First posted Nov 5, 2020

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

12 participants · First posted Oct 28, 2016

Validation of the GATE Software

30 participants · First posted Dec 23, 2010

Drugs

View all 492 →

GATE-101

GATE-301

GATE-102

Organizations

View all 277 →

Gate Neurosciences, Inc.

United States

Gate City Medical Equipment, Inc.

United States

INFLECTIS BIOSCIENCE

France

News

View all 1747 →

Gate Bioscience Partners with Lilly in $856 Million Deal to Develop Novel Molecular Gate Therapeutics

Gate Bioscience Raises $65 Million Series B to Advance Novel Oral Molecular Gate Therapies into Clinical Trials

GATE 2027: IIT Madras Revises Biotechnology Syllabus, Expands Two-Paper Combinations

Page 1 of 735